1. Home
  2. ROAD vs AXSM Comparison

ROAD vs AXSM Comparison

Compare ROAD & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROAD
  • AXSM
  • Stock Information
  • Founded
  • ROAD 2001
  • AXSM 2012
  • Country
  • ROAD United States
  • AXSM United States
  • Employees
  • ROAD N/A
  • AXSM N/A
  • Industry
  • ROAD Engineering & Construction
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROAD Industrials
  • AXSM Health Care
  • Exchange
  • ROAD Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • ROAD 6.9B
  • AXSM 5.9B
  • IPO Year
  • ROAD 2018
  • AXSM 2015
  • Fundamental
  • Price
  • ROAD $108.82
  • AXSM $151.51
  • Analyst Decision
  • ROAD Strong Buy
  • AXSM Strong Buy
  • Analyst Count
  • ROAD 4
  • AXSM 20
  • Target Price
  • ROAD $123.50
  • AXSM $176.00
  • AVG Volume (30 Days)
  • ROAD 459.2K
  • AXSM 586.9K
  • Earning Date
  • ROAD 11-20-2025
  • AXSM 11-03-2025
  • Dividend Yield
  • ROAD N/A
  • AXSM N/A
  • EPS Growth
  • ROAD 40.46
  • AXSM N/A
  • EPS
  • ROAD 1.84
  • AXSM N/A
  • Revenue
  • ROAD $2,812,356,000.00
  • AXSM $561,263,000.00
  • Revenue This Year
  • ROAD $22.85
  • AXSM $63.66
  • Revenue Next Year
  • ROAD $6.98
  • AXSM $54.46
  • P/E Ratio
  • ROAD $58.81
  • AXSM N/A
  • Revenue Growth
  • ROAD 54.20
  • AXSM 65.83
  • 52 Week Low
  • ROAD $64.79
  • AXSM $75.56
  • 52 Week High
  • ROAD $138.90
  • AXSM $152.94
  • Technical
  • Relative Strength Index (RSI)
  • ROAD 47.43
  • AXSM 70.84
  • Support Level
  • ROAD $95.01
  • AXSM $142.51
  • Resistance Level
  • ROAD $108.00
  • AXSM $152.94
  • Average True Range (ATR)
  • ROAD 4.94
  • AXSM 5.08
  • MACD
  • ROAD 0.19
  • AXSM 0.57
  • Stochastic Oscillator
  • ROAD 68.26
  • AXSM 91.54

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: